NO996442L - Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av søvnapnésyndromet - Google Patents

Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av søvnapnésyndromet

Info

Publication number
NO996442L
NO996442L NO996442A NO996442A NO996442L NO 996442 L NO996442 L NO 996442L NO 996442 A NO996442 A NO 996442A NO 996442 A NO996442 A NO 996442A NO 996442 L NO996442 L NO 996442L
Authority
NO
Norway
Prior art keywords
treatment
sleep apnea
receptors
manufacture
apnea syndrome
Prior art date
Application number
NO996442A
Other languages
English (en)
Other versions
NO325520B1 (no
NO996442D0 (no
Inventor
Francoise Cattelin
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO996442D0 publication Critical patent/NO996442D0/no
Publication of NO996442L publication Critical patent/NO996442L/no
Publication of NO325520B1 publication Critical patent/NO325520B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19996442A 1997-06-26 1999-12-23 Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av sovnapnesyndromet NO325520B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707998A FR2765107B1 (fr) 1997-06-26 1997-06-26 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
PCT/FR1998/001100 WO1999000119A1 (fr) 1997-06-26 1998-06-02 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil

Publications (3)

Publication Number Publication Date
NO996442D0 NO996442D0 (no) 1999-12-23
NO996442L true NO996442L (no) 2000-02-28
NO325520B1 NO325520B1 (no) 2008-06-02

Family

ID=9508467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19996442A NO325520B1 (no) 1997-06-26 1999-12-23 Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av sovnapnesyndromet

Country Status (28)

Country Link
US (1) US6143792A (no)
EP (1) EP1014960B1 (no)
JP (1) JP3503953B2 (no)
KR (1) KR20010014186A (no)
CN (1) CN1154485C (no)
AT (1) ATE232094T1 (no)
AU (1) AU728227B2 (no)
BG (1) BG104038A (no)
BR (1) BR9810337A (no)
CA (1) CA2295119C (no)
CZ (1) CZ291935B6 (no)
DE (1) DE69811248T2 (no)
EE (1) EE9900595A (no)
ES (1) ES2191942T3 (no)
FR (1) FR2765107B1 (no)
HU (1) HU229058B1 (no)
ID (1) ID23799A (no)
IL (1) IL133632A (no)
IS (1) IS2356B (no)
NO (1) NO325520B1 (no)
NZ (1) NZ502495A (no)
PL (1) PL190723B1 (no)
RU (1) RU2218917C2 (no)
SK (1) SK283845B6 (no)
TR (1) TR199903197T2 (no)
TW (1) TW580386B (no)
UA (1) UA59397C2 (no)
WO (1) WO1999000119A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321900C (en) 1998-02-27 2011-07-19 The Board Of Trustees Of The University Of Illinois Agents with serotonin-related activity for the treatment for sleep apnea
US7160898B2 (en) 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
FR2787328A1 (fr) * 1998-12-22 2000-06-23 Sanofi Sa Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
WO2000051582A2 (en) * 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
FR2804604B1 (fr) * 2000-02-09 2005-05-27 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
MXPA05000784A (es) * 2002-07-19 2005-06-17 Biovitrum Ab Derivados de piperazinil-pirazinona novedosos para el tratamiento de los trastornos relacionados con el receptor 5-ht2a.
CA2590802A1 (en) * 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
EP2266554A1 (en) * 2009-05-26 2010-12-29 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
JP2012508792A (ja) * 2008-11-13 2012-04-12 サノフイ エプリバンセリンを使用して睡眠障害を治療する方法
EP2186511A1 (en) * 2008-11-13 2010-05-19 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
EP2255726A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
EP2255807A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2269600A1 (en) * 2009-07-02 2011-01-05 Sanofi-Aventis Treatment of sleep disorders using eplivanserin in COPD patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
ZA912278B (en) * 1990-03-29 1992-11-25 Lilly Co Eli Compounds affecting serotonin receptors
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
IL103106A (en) * 1991-09-25 1998-06-15 Sanofi Elf Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them
RU2043125C1 (ru) * 1992-05-15 1995-09-10 Эдуард Арутюнович Петросян Способ профилактики осложнений неингаляционного наркоза

Also Published As

Publication number Publication date
CN1265586A (zh) 2000-09-06
WO1999000119A1 (fr) 1999-01-07
HU229058B1 (en) 2013-07-29
NZ502495A (en) 2000-10-27
SK184599A3 (en) 2000-06-12
NO325520B1 (no) 2008-06-02
CZ291935B6 (cs) 2003-06-18
AU728227B2 (en) 2001-01-04
ES2191942T3 (es) 2003-09-16
IS2356B (is) 2008-04-15
SK283845B6 (sk) 2004-03-02
US6143792A (en) 2000-11-07
BR9810337A (pt) 2000-09-05
CZ469599A3 (cs) 2000-04-12
HUP0002170A3 (en) 2001-12-28
FR2765107B1 (fr) 2000-03-24
IL133632A (en) 2003-10-31
EE9900595A (et) 2000-08-15
JP3503953B2 (ja) 2004-03-08
PL190723B1 (pl) 2005-12-30
DE69811248T2 (de) 2003-12-04
PL337871A1 (en) 2000-09-11
FR2765107A1 (fr) 1998-12-31
NO996442D0 (no) 1999-12-23
EP1014960B1 (fr) 2003-02-05
EP1014960A1 (fr) 2000-07-05
UA59397C2 (uk) 2003-09-15
HK1028351A1 (en) 2001-02-16
RU2218917C2 (ru) 2003-12-20
TR199903197T2 (xx) 2000-05-22
AU8024398A (en) 1999-01-19
BG104038A (en) 2001-04-30
HUP0002170A2 (hu) 2001-11-28
ID23799A (id) 2000-05-11
CA2295119C (en) 2007-02-13
DE69811248D1 (de) 2003-03-13
JP2001520678A (ja) 2001-10-30
IL133632A0 (en) 2001-04-30
ATE232094T1 (de) 2003-02-15
TW580386B (en) 2004-03-21
CA2295119A1 (en) 1999-01-07
IS5316A (is) 1999-12-21
KR20010014186A (ko) 2001-02-26
CN1154485C (zh) 2004-06-23

Similar Documents

Publication Publication Date Title
NO996442D0 (no) Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av forstyrret pusting under søvn
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
KR960700059A (ko) 파킨슨씨 병 및 파킨슨 중후군의 치료에 카르바마제핀 및 옥스카르바제핀의 이용(application of carbamazepine and oxcarbazepine in the treatment of parkinson&#39;s disease and parkinsonian syndromes)
BR0015188A (pt) Composições farmacêuticas
ATE450508T1 (de) Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
HU9603228D0 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
ID26128A (id) Senyawa-senyawa aminotetralin tersubstitusi-n sebagai ligan-ligan untuk reseptor neupeptida y y5 yang bermanfaat dalam pengobatan obesitas dan gangguan-gangguan lain
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
DK1588706T3 (da) Valsartantablet
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
AU8361198A (en) Novel compounds
FR2718020B1 (fr) Composition galénique mucoadhésive hétérofonctionnelle.
IL206566A0 (en) Use of an antagonist to the igs4 neuromedin receptor polypeptide for the preparation of a medicament for the treatment of a disease related to the expression or acitivity of the igs4 neuromedin receptor polypeptide
AR029637A1 (es) Compuestos de guanidina, antagonistas de los receptores de la il-8, una composicion farmaceutica que los contiene y el uso de los mismos para la manufactura de un medicamento
MXPA04001847A (es) Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad.
HUP0203338A2 (hu) Integrin receptor ligandumok
IS2702B (is) Notkun á (11beta, 17beta)-11-(1,3-bensódíoxól-5-ýl)-17-hýdroxý-17-(1-própýnýl)-estra-4,9-díen-3-ón í meðhöndluninni á alvarlegri geðdeyfðartruflun
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
MXPA01006319A (es) Uso de los antagonistas del receptor para 5ht, para el tratamiento de sindrome de fatiga cronica.
IL143143A0 (en) USE OF A 5HT2A AND 5HT2A/C RECEPTOR ANTAGONIST FOR PREPARING MEDICINES FOR TREATING SNORING AND HIGH RESISTAnCE SYNDROME OF UPPER ANATOMICAL AIRWAYS
BR0314945A (pt) Uso de antagonistas de receptor 5-ht2 para tratamento de distúrbios de sono
WO2004002399A3 (en) Use of gaba-c receptor antagonists for the treatment of myopia
MX9400288A (es) Procedimiento para la preparacion de un medicamento util como radiorestaurador.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees